Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II—An Updated Analysis of SEER-Medicare Data

Assessing Cost of Robotic Utilization in Partial Nephrectomy with Increasing Utilization

(2018) Clinton D Bahler et al.   JOURNAL OF ENDOUROLOGY

Economic Burden of Renal Cell Carcinoma—Part I: An Updated Review

(2018) Chun-Ru Chien et al.   PHARMACOECONOMICS

Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries

(2017) Ya-Chen Tina Shih et al.   JOURNAL OF CLINICAL ONCOLOGY

Minimally invasive vs open nephrectomy in the modern era: does approach matter?

(2017) David M. Golombos et al.   WORLD JOURNAL OF UROLOGY

Treatment Patterns and Costs for Metastatic Renal Cell Carcinoma Patients With Private Insurance in the United States

(2015) Daniel M. Geynisman et al.   Clinical Genitourinary Cancer

Trends in the Cost and Use of Targeted Cancer Therapies for the Privately Insured Nonelderly: 2001 to 2011

(2015) Ya-Chen Tina Shih et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007

(2013) Keith J. Kowalczyk et al.   BJU INTERNATIONAL

Projections of the Cost of Cancer Care in the United States: 2010-2020

(2011) A. B. Mariotto et al.   JNCI-Journal of the National Cancer Institute

Overview of Methods to Estimate the Medical Costs of Cancer

(2009) William E. Barlow   MEDICAL CARE

Health Care Costing: Data, Methods, Current Applications

(2009) Joseph Lipscomb et al.   MEDICAL CARE

Cost of Care for Elderly Cancer Patients in the United States

(2008) K. Robin Yabroff et al.   JNCI-Journal of the National Cancer Institute